The innovative programs of the Baruch S. Blumberg Institute include a large natural products library, donated to us by Merck & Co. in 2011, and a screening program for hepatitis B drug discovery. In addition, our state-of-the-art proteomics facility utilizes two mass spectrometers to examine proteins and other molecules from those chronically infected with hepatitis with the goal of developing early markers of liver disease and liver cancer. Our biotechnology outreach offers a unique and exceptional opportunity to bring scientists together from commercial, academic and other nonprofit institutions to pursue common research themes in an environment conducive to interaction, collaboration and focus.